Catalyst Wire Dossier Catalyst Wire Dossier

Investigational gene therapy for chronic stable angina (NCT01002495)

· Helixmith Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational gene therapy for chronic stable angina (NCT01002495), covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for the Treatment of Chronic Stable Angina [Phase 1, Phase 2]

See pricing